Publication | Closed Access

Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Cytoreductive SurgerySurgical OncologyTen-year Single-center ExperienceMedicineSurgical PathologySurgeryOncologyRadiation OncologyHyperthermic Intraperitoneal Chemotherapy